1971
DOI: 10.1111/j.1749-6632.1971.tb30762.x
|View full text |Cite
|
Sign up to set email alerts
|

Germine Mono‐ and Diacetate in Myasthenia Gravis*

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1973
1973
1978
1978

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…Subsequently, it has been demonstrated that a semisynthetic veratrum alkaloid, germine-3.16-diacetate (GDA) has a similar effect (Flacke, 1963). First, this compound (Flaclee et al, 1966) and, later, the more active germine-3-monoacetate (GMA) (Flacke et al, 1971) were used for the treatment of myasthenia gravis. Both GDA (Flaclee et al, 1968) and GMA (Katz, R. L., personal communication) were also employed for the improvement of muscle function in partially curarized patients at the end of anaesthesia.…”
Section: Introductionmentioning
confidence: 99%
“…Subsequently, it has been demonstrated that a semisynthetic veratrum alkaloid, germine-3.16-diacetate (GDA) has a similar effect (Flacke, 1963). First, this compound (Flaclee et al, 1966) and, later, the more active germine-3-monoacetate (GMA) (Flacke et al, 1971) were used for the treatment of myasthenia gravis. Both GDA (Flaclee et al, 1968) and GMA (Katz, R. L., personal communication) were also employed for the improvement of muscle function in partially curarized patients at the end of anaesthesia.…”
Section: Introductionmentioning
confidence: 99%